Elisabetta Abruzzese

Elisabetta Abruzzese

UNVERIFIED PROFILE

Are you Elisabetta Abruzzese?   Register this Author

Register author
Elisabetta Abruzzese

Elisabetta Abruzzese

Publications by authors named "Elisabetta Abruzzese"

Are you Elisabetta Abruzzese?   Register this Author

100Publications

2973Reads

32Profile Views

"Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay." Is dPCR the key?

Eur J Haematol 2019 09 7;103(3):272-273. Epub 2019 Jul 7.

Unit of Blood Diseases and Stem Cell Transplantation, DPT of Clinical and Experimental Sciences, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13282DOI Listing
September 2019

Back to the future: Treatment-free remission and pregnancy in chronic myeloid leukemia.

Eur J Haematol 2019 Feb 29;102(2):197-199. Epub 2018 Nov 29.

Memorial Sloan Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.13192
Publisher Site
http://dx.doi.org/10.1111/ejh.13192DOI Listing
February 2019

Chronic myeloproliferative disorders: is quality-of-life the new goal?

Curr Med Res Opin 2018 07 1;34(7):1345-1347. Epub 2018 Jun 1.

a Hematology, St. Eugenio Hospital , Tor Vergata University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2018.1473245DOI Listing
July 2018

Sexual health in patients with hematological malignancies: a neglected issue.

Support Care Cancer 2018 Jun 3;26(6):1699-1701. Epub 2018 Mar 3.

Hematology Unit, Sant'Eugenio Hospital, Piazzale dell'Umanesimo, 10, 00144, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4124-2DOI Listing
June 2018

HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia.

Leuk Res 2017 10 18;61:1-5. Epub 2017 Aug 18.

Hematology Unit, Department of Medical Sciences and Public Health, Bone Marrow Transplant Center, R. Binaghi Hospital, University of Cagliari, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.08.005DOI Listing
October 2017

The DESTINY of chronic myeloid leukeamia.

Lancet Haematol 2017 07 26;4(7):e303-e304. Epub 2017 May 26.

Department of Hematology, S Eugenio Hospital, Tor Vergata University, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(17)30087-XDOI Listing
July 2017

Primitive "Spindle Cell Variant" (Sarcomatoid Variant) Diffuse Large B-Cell Lymphoma of the Uterine Cervix: Description and Outcome of a Rare Case.

Int J Gynecol Pathol 2016 Nov;35(6):593-597

Diagnostic Surgical Pathology Unit (S.F., G.S.) Hematology Unit (E.A., M.M.T., P.N., P.D.F.), S. Eugenio Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000294DOI Listing
November 2016

Management of pregnant chronic myeloid leukemia patients.

Expert Rev Hematol 2016 Aug 7;9(8):781-91. Epub 2016 Jul 7.

b Department of Hematology & Oncology 'L. and A. Seràgnoli' , S.Orsola-Malpighi University Hospital , Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1205479DOI Listing
August 2016

Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients.

J Hematol Oncol 2016 07 29;9(1):63. Epub 2016 Jul 29.

Hematology Unit, Department of Medical Sciences, Bone Marrow Transplant Center, R. Binaghi Hospital, University of Cagliari, Ospedale "R. Binaghi", Via Is Guadazzonis, 3, 09126, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-016-0293-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966800PMC
July 2016

Cutaneous Lesions Anticipating Accelerated Phase of Multidrug Resistant Chronic Myeloid Leukemia Responsive to Ponatinib.

Mediterr J Hematol Infect Dis 2016 20;8(1):e2016016. Epub 2016 Feb 20.

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2016.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771144PMC
March 2016

Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients.

Exp Hematol 2015 Dec 22;43(12):1015-1018.e1. Epub 2015 Aug 22.

Hematology Unit, Department of Medical Sciences, Bone Marrow Transplant Center, R. Binaghi Hospital, University of Cagliari, Cagliari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2015.08.004DOI Listing
December 2015

The impact of dasatinib on pregnancy outcomes.

Am J Hematol 2015 Dec 12;90(12):1111-5. Epub 2015 Oct 12.

Centre for Haematology, Imperial College, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115878PMC
December 2015

Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.

Mediterr J Hematol Infect Dis 2015 15;7(1):e2015020. Epub 2015 Feb 15.

Elisabetta Abruzzese, MD, PhD, Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2015.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344172PMC
March 2015

Tyrosine kinase inhibitors and pregnancy.

Mediterr J Hematol Infect Dis 2014 7;6(1):e2014028. Epub 2014 Apr 7.

Hematology, S. Eugenio Hospital, Tor Vergata University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2014.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010610PMC
June 2014

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

J Clin Oncol 2014 Apr 17;32(12):1188-94. Epub 2014 Mar 17.

John M.M. Raemaekers and Richard van der Maazen, Radboud University Medical Center, Nijmegen; Pieternella J. Lugtenburg, Erasmus University Medical Center, Rotterdam; Gustaaf van Imhoff, University Medical Centre Groningen, Groningen, the Netherlands; Marc P.E. André and Thierry van der Borght, Centre Hospitalier Universitaire (CHU) L'Université Catholique de Louvain Mont Godinne, Yvoir; Yolande Lievens, Ghent University Hospital, Ghent; Tiana Raveloarivahy and Catherine Fortpied, European Organisation for Research and Treatment of Cancer, Brussels, Belgium; Massimo Federico and Monica Bellei, University of Modena and Reggio Emilia, Modena; Ercole Brusamolino, Istituto Clinico Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan; Manuel Gotti, Fondazione IRCCS Policlinico San Matteo, Pavia; Allessandro Re, Spedali Civili Hospital, Brescia; Elisabetta Abruzzese, San Eugenio Hospital, Tor Vergata University, Rome; Annibale Versari, Arcispedale Santa Maria Nuova, IRCCS di Reggio Emilia, Reggio Emilia, Italy; Theodore Girinsky and Christophe Fermé, Institut Gustave Roussy, Villejuif; Reman Oumedaly, CHU Caen; Stephane Bardet, Centre Francois Baclesse, Caen; Pauline Brice, Hôpital Saint-Louis, Paris; Reda Bouabdallah, Institut Paoli Calmette, Marseille; Catherine J. Sebban, Centre Léon Bérard, Lyon; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Frank Morschhauser, CHU de Lille, Lille; Pierre Olivier, CHU Nancy, Nancy; Rene-Olivier Casasnovas, CHU de Dijon, Dijon; Michel Meignan, Hôpital Henri Mondor, Creteil, France; and Martin Hutchings, Rigshospitalet, Kopenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.9298DOI Listing
April 2014

Second-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukaemia (CML).

BioDrugs 2014 Feb;28(1):17-26

Hematology, S. Eugenio Hospital, Tor Vergata University, P. le dell'Umanesimo 10, 00144, Rome, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-013-0056-zDOI Listing
February 2014

Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients.

Cancer 2010 Dec 24;116(24):5667-75. Epub 2010 Aug 24.

Institute of Hematology and Medical Oncology L. e A. Seràgnoli, Policlinico Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25307DOI Listing
December 2010

153Sm: its use in multiple myeloma and report of a clinical experience.

Expert Opin Investig Drugs 2008 Sep;17(9):1379-87

Tor Vergata University, S. Eugenio Hospital, Hematology, P.le dell'Umanesimo 10, 00144 Rome, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/13543784.17.9.13
Publisher Site
http://dx.doi.org/10.1517/13543784.17.9.1379DOI Listing
September 2008